WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Dana PizzutiChief Med and Dev Officer2024-04-1514,375$16.89
$242.79kBuy
Richard Scott StruthersPresident CEO2024-04-1520,000$1.91
$38.20kBuy
Dana PizzutiChief Med and Dev Officer2024-04-1514,375$44.47
$639.26kSell
Richard Scott StruthersPresident CEO2024-04-0440,951$9.28
$380.03kBuy
Richard Scott StruthersPresident CEO2024-04-0440,951$49.17
$2.01MSell
Stephanie OkeyDirector2024-03-2817,500$18.29
$320.08kBuy
Stephanie OkeyDirector2024-03-2817,500$46.38
$811.65kSell
Jeff E. KnightChief Operating Officer2024-03-2230,000$23.98
$719.40kBuy
Jeff E. KnightChief Operating Officer2024-03-222,359$45.39
$107.08kSell
Jeff E. KnightChief Operating Officer2024-03-2230,000$44.22
$1.33MSell

1 of 7

CRNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC11.36%7,908,985$340.17MInsider
Blackrock Inc7.68%5,345,114$229.89MInstitution
Driehaus Capital Management LLC7.24%5,039,957$216.77MInstitution
Fmr LLC5.81%4,043,865$173.93MInstitution
State Street Corp5.12%3,563,736$153.28MInstitution
Vanguard Group Inc5.03%3,502,452$150.64MInstitution
Point72 Asset Management LP4.91%3,416,900$146.96MInstitution
Wellington Management Group LLP4.66%3,245,105$139.57MInstitution
Price T Rowe Associates Inc4.32%3,008,858$129.41MInstitution
Jennison Associates LLC3.66%2,547,683$109.58MInstitution

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX85.00%15.00%Net SellingNet Selling
XENE95.45%3.29%Net SellingNet Selling
SWTX64.08%35.92%Net SellingNet Selling
FOLD66.56%33.44%Net SellingNet Selling
IOVA16.06%83.94%Net BuyingNet Buying
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 101.52% institutional shareholders, 17.91% Crinetics Pharmaceuticals insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 11.36% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $339.85M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.